Mandarin Capital Partners sells pharmaceutical manufacturer Mipharm to Alto Partners

Acquisition, Cross border deal, Private equity deal – Secondary

Mipharm, a Milan-based company recognized among the Italian leaders in the CDMO (Contract Development and Manufacturing Organization) industry, today saw 100% of its capital changing hands: Mandarin Capital Partners II (MCP) sold its stake to the private equity fund Alto Partners, together with the shares held by the President and CEO Maurizio Silvestri (through Euteam), Cassiopea Partners and other managers.

Click here to read the press release

Target – MIPHARM S.P.A.
Seller – Mandarin Investment Management S.A
Seller – Maurizio Silvestri (Private Investor)

Bridgepoint Advisers has agreed to acquire Alpha FMC

Bridgepoint Group Limited, the UK based private equity firm, through its UK based indirect subsidiary Actium Bidco (UK) Limited, has …

Read More →

Bridgepoint Advisers to make an offer for Alpha Financial

Bridgepoint Group Limited, the UK based private equity firm, through its UK based indirect subsidiary Actium Bidco (UK) Limited, has …

Read More →

Wakeo acquires Veroo Software

Wakeo, the France based provider of a SaaS platform providing real-time visibility on international transport flows (sea, air, road) to …

Read More →

Bregal Unternehmerkapital to acquire a majority stake in Relatech S.p.A.

Bregal Unternehmerkapital GmbH, the Germany based private equity firm, through Gemini BidCo, a special purpose vehicle indirectly controlled by the …

Read More →

DeepForm raises GBP 2m

DeepForm Limited, the UK based company, that specializes in developing and offering novel press tool designs, which help reduce material …

Read More →

PINOVA Capital invests in NEUROMEDEX

Neuromedex, the Germany based provider of disposable products for neurosurgery and intensive care, has been acquired by Pinova Capital GmbH, …

Read More →
close-link
close-link